眼部药物输送市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00004206
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 171
Buy Now

2021年眼部给药市场价值为164.0432亿美元,预计到2028年将达到270.162亿美元;预计 2021 年至 2028 年复合年增长率为 7.4%。

眼部药物递送系统 (ODDS) 是一种剂型、载体或药物旨在向眼睛滴注、施用或输送药物/药物以预防涉及或影响视力的任何疾病或障碍的系统。它的范围从简单的用于眼表的无菌滴眼剂到用于眼内组织的复杂的植入物。眼部药物制剂主要是液体形式,例如用于治疗眼前段疾病的溶液剂、混悬剂和乳剂。这些制剂可以以先进的药物递送系统的形式提供,例如原位凝胶、微乳液、纳米颗粒、脂质体、离子电渗疗法、纳米混悬剂和眼部植入物。    

战略洞察                      

眼部药物输送市场已根据技术、制剂类型、疾病类型、最终用户和地理位置进行细分。按地域划分,市场主要分为北美、欧洲、亚太地区、中东和中东地区。非洲、南美和非洲中美洲。该报告提供了对眼部药物输送市场的见解和深入分析,强调了市场趋势、技术进步和市场动态等参数,以及全球领先市场参与者的竞争格局分析。

眼部给药市场利润丰厚的区域

市场洞察
眼部疾病患病率不断上升,促进眼部药物输送市场增长

全球失明或低视力的主要原因是白内障、青光眼、年龄相关的黄斑变性、糖尿病性视网膜病变和未解决的屈光不正。全球大多数人一生中都患有或患有某种眼部疾病。根据世界卫生组织 (WHO) 报告“失明和视力障碍” 2021 年 2 月发布的报告显示,全球约有 22 亿人存在近视力或远视力障碍。据估计,视力丧失或低视力的主要原因是白内障(9400万)和未矫正的屈光不正(8840万)。此外,视力丧失的其他常见原因包括青光眼(770 万)、角膜混浊(420 万)、糖尿病性视网膜病变(390 万)和沙眼(200 万)。

根据美国国家眼科研究所 (NEI) 的数据,到 2050 年,美国白内障患者数量预计将从 2010 年的 2,440 万人增加一倍,达到约 5,000 万人。据统计,2019 年美国有超过 300 万人患有青光眼。此外,根据 2017 年加拿大残疾人调查,150 万加拿大人视力丧失,约 559 万人患有可能进一步导致视力丧失的眼部疾病。

此外,根据皇家国家盲人研究所 2017 年的数据,英国约有 35 万人登记为盲人和弱视;约有 173,735 人登记为严重视力障碍; 176,125 人登记为视力障碍者。

基于技术的见解            ;              

以技术为基础,眼部给药市场是分为植入式眼部给药系统、颗粒给药系统、纳米颗粒给药系统等。植入式眼部给药系统细分市场将在 2021 年占据最大的市场份额,预计该细分市场在预测期内复合年增长率最高。

眼部药物输送市场(按技术) 2021 年和 2028 年

基于配方类型的见解       ;                

根据制剂类型,眼科药物递送市场分为脂质体和纳米颗粒、溶液、乳液、悬浮液和软膏。解决方案领域将在 2021 年占据最大的市场份额,预计 2021 年至 2028 年市场复合年增长率最高。解决方案领域的增长归因于越来越多地采用溶液形式的眼部药物输送系统,例如滴眼剂和注射剂。

基于疾病类型的见解

根据疾病类型,眼部给药市场分为青光眼、糖尿病视网膜病变、干眼综合征、黄斑变性、白内障、糖尿病黄斑水肿等。白内障细分市场将在 2021 年占据最大的市场份额。预计从 2021 年到 2028 年,该细分市场的复合年增长率将达到最高。

最终用户–基于洞察

根据最终用户,眼部给药市场分为医院、眼科诊所和门诊手术中心。到 2021 年,医院细分市场将占据最大的市场份额,而眼科诊所细分市场预计在预测期内的复合年增长率最高。

< p>COVID-19 大流行已成为全世界最重大的挑战。由于这场大流行给全球医疗保健系统带来了压力,因此优先考虑有限的资源对于最大限度地减少住院人数至关重要。然而,尽管对眼药水、眼膏和混悬剂等眼部治疗药物的需求增加,但随着新消费者进入市场,这些产品仍然短缺。由于供应限制,制造商还面临着价格上涨和原材料潜在短缺的问题。不过,随着限制的解除和企业的恢复,供需变量正在恢复正常。这将为眼部药物输送疗法带来多种增长前景。

收购、合作、伙伴关系、产品发布和扩张是公司在全球范围内扩大业务并满足不断增长的需求。眼部给药市场参与者主要采取产品创新策略来满足全球不断变化的客户需求,这也有助于他们在全球范围内保持品牌声誉。

< p>公司简介

  • 艾伯维公司               ;                    
  • 博士健康公司有限公司              
  • 台湾脂质体股份有限公司            
  • 眼科治疗公司                      
  • 灰虫视觉有限公司                     
  • Alimera Sciences, Inc.          
  • Envisia Therapeutics                           
  • 诺华公司                                
  • EYEGATE PHARMACEUTICALS, INC           
  • Clearside Biomedical, Inc.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is ocular drug delivery?

Ocular drug delivery system (ODDS) is a dosage form, vehicle, or system intended for instilling, administering, or delivering drug/medicine to eye against any ailment or disorder involving or affecting vision. It ranges from simple sterile eye drop for the ocular surface to complex implants for intraocular tissue. Ocular drugs formulations are primarily available in liquid form such as solutions, suspensions, and emulsions for treating anterior eye segment diseases. These formulations can be available in the form of advanced drug delivery systems like in-situ gel, microemulsion, nanoparticle, liposome, iontophoresis, nanosuspension, and ocular inserts.

What are the driving factors for the Ocular drug delivery market across the globe?

The factors that are driving growth of the market are growing prevalence of eye disorders and rising research on ocular drug delivery.

What are the challenges hindering the adoption of Ocular drug delivery?

The factors that are restraining the adoption of ocular drug delivery are several disadvantages associated with ocular drug delivery.

Who are the major players in the Ocular drug delivery market?

The Ocular drug delivery market majorly consists of the players such as players AbbVie Inc., Bausch Health Companies Inc., Taiwan Liposome Company, Ltd., Ocular Therapeutix, Inc., Graybug Vision, Inc., Alimera Sciences, Inc., Envisia Therapeutics, Novartis AG, EyeGate Pharmaceuticals, Inc, Clearside Biomedical, Inc. and among others.

The List of Companies - Ocular Drug Delivery Market

  1. AbbVie Inc.          
  2. Bausch Health Companies Inc.      
  3. Taiwan Liposome Company, Ltd.              
  4. Ocular Therapeutix, Inc.    
  5. GRAYBUG VISION, INC.               
  6. Alimera Sciences, Inc.      
  7. Envisia Therapeutics         
  8. Novartis AG         
  9. EYEGATE PHARMACEUTICALS, INC        
  10. Clearside Biomedical, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports